Hereditary breast cancer in Middle Eastern and North African (MENA) populations

Identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population

Wijden Mahfoudh, Noureddine Bouaouina, Slim Ben Ahmed, Sallouha Gabbouj, Jingxuan Shan, Rebecca A. Mathew, Nancy Uhrhammer, Yves Jean Bignon, Wafa Troudi, Amel Ben Ammar Elgaaied, Elham Hassen, Lotfi Chouchane

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Germ-line mutations in BRCA1 breast cancer susceptibility gene account for a large proportion of hereditary breast cancer families and show considerable ethnic and geographical variations. The contribution of BRCA1 mutations to hereditary breast cancer has not yet been thoroughly investigated in Middle Eastern and North African populations. In this study, 16 Tunisian high-risk breast cancer families were screened for germline mutations in the entire BRCA1 coding region and exon-intron boundaries using direct sequencing. Six families were found to carry BRCA1 mutations with a prevalence of 37.5%. Four different deleterious mutations were detected. Three truncating mutations were previously described: c.798-799delTT (916 delTT), c.3331-3334delCAAG (3450 delCAAG), c.5266dupC (5382 insC) and one splice site mutation which seems to be specific to the Tunisian population: c.212 + 2insG (IVS5 + 2insG). We also identified 15 variants of unknown clinical significance. The c.798-799delTT mutation occurred at an 18% frequency and was shared by three apparently unrelated families. Analyzing five microsatellite markers in and flanking the BRCA1 locus showed a common haplotype associated with this mutation. This suggests that the c.798-799delTT mutation is a Tunisian founder mutation. Our findings indicate that the Tunisian population has a spectrum of prevalent BRCA1 mutations, some of which appear as recurrent and founding mutations.

Original languageEnglish
Pages (from-to)1037-1046
Number of pages10
JournalMolecular Biology Reports
Volume39
Issue number2
DOIs
Publication statusPublished - Feb 2012

Fingerprint

Breast Neoplasms
Mutation
Population
Germ-Line Mutation
Neoplasm Genes
Microsatellite Repeats
Introns
Haplotypes
Exons

Keywords

  • BRCA1 mutations
  • Founder effect
  • Hereditary breast cancer
  • Tunisians

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Hereditary breast cancer in Middle Eastern and North African (MENA) populations : Identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population. / Mahfoudh, Wijden; Bouaouina, Noureddine; Ahmed, Slim Ben; Gabbouj, Sallouha; Shan, Jingxuan; Mathew, Rebecca A.; Uhrhammer, Nancy; Bignon, Yves Jean; Troudi, Wafa; Ammar Elgaaied, Amel Ben; Hassen, Elham; Chouchane, Lotfi.

In: Molecular Biology Reports, Vol. 39, No. 2, 02.2012, p. 1037-1046.

Research output: Contribution to journalArticle

Mahfoudh, Wijden ; Bouaouina, Noureddine ; Ahmed, Slim Ben ; Gabbouj, Sallouha ; Shan, Jingxuan ; Mathew, Rebecca A. ; Uhrhammer, Nancy ; Bignon, Yves Jean ; Troudi, Wafa ; Ammar Elgaaied, Amel Ben ; Hassen, Elham ; Chouchane, Lotfi. / Hereditary breast cancer in Middle Eastern and North African (MENA) populations : Identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population. In: Molecular Biology Reports. 2012 ; Vol. 39, No. 2. pp. 1037-1046.
@article{94137c83305342afa4ea17c96adaa0fd,
title = "Hereditary breast cancer in Middle Eastern and North African (MENA) populations: Identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population",
abstract = "Germ-line mutations in BRCA1 breast cancer susceptibility gene account for a large proportion of hereditary breast cancer families and show considerable ethnic and geographical variations. The contribution of BRCA1 mutations to hereditary breast cancer has not yet been thoroughly investigated in Middle Eastern and North African populations. In this study, 16 Tunisian high-risk breast cancer families were screened for germline mutations in the entire BRCA1 coding region and exon-intron boundaries using direct sequencing. Six families were found to carry BRCA1 mutations with a prevalence of 37.5{\%}. Four different deleterious mutations were detected. Three truncating mutations were previously described: c.798-799delTT (916 delTT), c.3331-3334delCAAG (3450 delCAAG), c.5266dupC (5382 insC) and one splice site mutation which seems to be specific to the Tunisian population: c.212 + 2insG (IVS5 + 2insG). We also identified 15 variants of unknown clinical significance. The c.798-799delTT mutation occurred at an 18{\%} frequency and was shared by three apparently unrelated families. Analyzing five microsatellite markers in and flanking the BRCA1 locus showed a common haplotype associated with this mutation. This suggests that the c.798-799delTT mutation is a Tunisian founder mutation. Our findings indicate that the Tunisian population has a spectrum of prevalent BRCA1 mutations, some of which appear as recurrent and founding mutations.",
keywords = "BRCA1 mutations, Founder effect, Hereditary breast cancer, Tunisians",
author = "Wijden Mahfoudh and Noureddine Bouaouina and Ahmed, {Slim Ben} and Sallouha Gabbouj and Jingxuan Shan and Mathew, {Rebecca A.} and Nancy Uhrhammer and Bignon, {Yves Jean} and Wafa Troudi and {Ammar Elgaaied}, {Amel Ben} and Elham Hassen and Lotfi Chouchane",
year = "2012",
month = "2",
doi = "10.1007/s11033-011-0829-8",
language = "English",
volume = "39",
pages = "1037--1046",
journal = "Molecular Biology Reports",
issn = "0301-4851",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Hereditary breast cancer in Middle Eastern and North African (MENA) populations

T2 - Identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population

AU - Mahfoudh, Wijden

AU - Bouaouina, Noureddine

AU - Ahmed, Slim Ben

AU - Gabbouj, Sallouha

AU - Shan, Jingxuan

AU - Mathew, Rebecca A.

AU - Uhrhammer, Nancy

AU - Bignon, Yves Jean

AU - Troudi, Wafa

AU - Ammar Elgaaied, Amel Ben

AU - Hassen, Elham

AU - Chouchane, Lotfi

PY - 2012/2

Y1 - 2012/2

N2 - Germ-line mutations in BRCA1 breast cancer susceptibility gene account for a large proportion of hereditary breast cancer families and show considerable ethnic and geographical variations. The contribution of BRCA1 mutations to hereditary breast cancer has not yet been thoroughly investigated in Middle Eastern and North African populations. In this study, 16 Tunisian high-risk breast cancer families were screened for germline mutations in the entire BRCA1 coding region and exon-intron boundaries using direct sequencing. Six families were found to carry BRCA1 mutations with a prevalence of 37.5%. Four different deleterious mutations were detected. Three truncating mutations were previously described: c.798-799delTT (916 delTT), c.3331-3334delCAAG (3450 delCAAG), c.5266dupC (5382 insC) and one splice site mutation which seems to be specific to the Tunisian population: c.212 + 2insG (IVS5 + 2insG). We also identified 15 variants of unknown clinical significance. The c.798-799delTT mutation occurred at an 18% frequency and was shared by three apparently unrelated families. Analyzing five microsatellite markers in and flanking the BRCA1 locus showed a common haplotype associated with this mutation. This suggests that the c.798-799delTT mutation is a Tunisian founder mutation. Our findings indicate that the Tunisian population has a spectrum of prevalent BRCA1 mutations, some of which appear as recurrent and founding mutations.

AB - Germ-line mutations in BRCA1 breast cancer susceptibility gene account for a large proportion of hereditary breast cancer families and show considerable ethnic and geographical variations. The contribution of BRCA1 mutations to hereditary breast cancer has not yet been thoroughly investigated in Middle Eastern and North African populations. In this study, 16 Tunisian high-risk breast cancer families were screened for germline mutations in the entire BRCA1 coding region and exon-intron boundaries using direct sequencing. Six families were found to carry BRCA1 mutations with a prevalence of 37.5%. Four different deleterious mutations were detected. Three truncating mutations were previously described: c.798-799delTT (916 delTT), c.3331-3334delCAAG (3450 delCAAG), c.5266dupC (5382 insC) and one splice site mutation which seems to be specific to the Tunisian population: c.212 + 2insG (IVS5 + 2insG). We also identified 15 variants of unknown clinical significance. The c.798-799delTT mutation occurred at an 18% frequency and was shared by three apparently unrelated families. Analyzing five microsatellite markers in and flanking the BRCA1 locus showed a common haplotype associated with this mutation. This suggests that the c.798-799delTT mutation is a Tunisian founder mutation. Our findings indicate that the Tunisian population has a spectrum of prevalent BRCA1 mutations, some of which appear as recurrent and founding mutations.

KW - BRCA1 mutations

KW - Founder effect

KW - Hereditary breast cancer

KW - Tunisians

UR - http://www.scopus.com/inward/record.url?scp=84860318904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860318904&partnerID=8YFLogxK

U2 - 10.1007/s11033-011-0829-8

DO - 10.1007/s11033-011-0829-8

M3 - Article

VL - 39

SP - 1037

EP - 1046

JO - Molecular Biology Reports

JF - Molecular Biology Reports

SN - 0301-4851

IS - 2

ER -